These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

375 related items for PubMed ID: 9720464

  • 41. Susceptibility patterns of bacterial isolates from hospitalised patients with respiratory tract infections (MOXIAKTIV Study).
    Jacobs E, Dalhoff A, Korfmann G.
    Int J Antimicrob Agents; 2009 Jan; 33(1):52-7. PubMed ID: 18835763
    [Abstract] [Full Text] [Related]

  • 42. Antimicrobial resistance in respiratory tract pathogens: results of an international surveillance study.
    Thornsberry C, Sahm DF.
    Chemotherapy; 2000 Jan; 46 Suppl 1():15-23. PubMed ID: 10810209
    [Abstract] [Full Text] [Related]

  • 43. [In vitro activity of moxifloxacin against respiratory pathogens in Latin America].
    López H, Sader H, Amábile C, Pedreira W, Muñoz Bellido JL, García Rodríguez JA, Grupo MSP-LA.
    Rev Esp Quimioter; 2002 Dec; 15(4):325-34. PubMed ID: 12587037
    [Abstract] [Full Text] [Related]

  • 44. Susceptibility of European respiratory tract isolates to trovafloxacin, ciprofloxacin, clarithromycin, azithromycin and ampicillin.
    Pontani D, Washton H, Bouchillon S, Johnson J.
    Eur J Clin Microbiol Infect Dis; 1998 Jun; 17(6):413-9. PubMed ID: 9758284
    [Abstract] [Full Text] [Related]

  • 45. The in vitro effects of faropenem on lower respiratory tract pathogens isolated in the United Kingdom.
    Walsh F, Amyes AK, Amyes SG.
    Int J Antimicrob Agents; 2003 Jun; 21(6):581-4. PubMed ID: 12791474
    [Abstract] [Full Text] [Related]

  • 46. In vitro activity of telithromycin against respiratory tract pathogens in comparison with other antimicrobial agents.
    Ling TK, Lee CC.
    Chemotherapy; 2005 Jul; 51(4):182-5. PubMed ID: 15980628
    [Abstract] [Full Text] [Related]

  • 47. In vitro activity of the novel ketolide HMR 3647 and comparative oral antibiotics against Canadian respiratory tract isolates of Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis.
    Hoban DJ, Zhanel GG, Karlowsky JA.
    Diagn Microbiol Infect Dis; 1999 Sep; 35(1):37-44. PubMed ID: 10529880
    [Abstract] [Full Text] [Related]

  • 48. AWARE Ceftaroline Surveillance Program (2008-2010): trends in resistance patterns among Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis in the United States.
    Pfaller MA, Farrell DJ, Sader HS, Jones RN.
    Clin Infect Dis; 2012 Sep; 55 Suppl 3():S187-93. PubMed ID: 22903951
    [Abstract] [Full Text] [Related]

  • 49. Antimicrobial susceptibility of Streptococcus pneumoniae, Haemophilus influenzae and Moraxella catarrhalis collected from five centers in Brazil, 1997-98.
    Critchley IA, Thornsberry C, Piazza G, Jones M, Hickey ML, Barth AL, Mendes C, Rossi FF, Sader HS, Teixeira LM, Sahm DF.
    Clin Microbiol Infect; 2000 Apr; 6(4):178-84. PubMed ID: 11168105
    [Abstract] [Full Text] [Related]

  • 50. In vitro activity of trovafloxacin (CP-99,219), sparfloxacin, ciprofloxacin, and fleroxacin against respiratory pathogens.
    Crokaert F, Aoun M, Duchateau V, Grenier P, Vandermies A, Klastersky J.
    Eur J Clin Microbiol Infect Dis; 1996 Aug; 15(8):696-8. PubMed ID: 8894585
    [No Abstract] [Full Text] [Related]

  • 51. Benchmarking the in vitro activity of moxifloxacin against recent isolates of Streptococcus pneumoniae, Moraxella catarrhalis, and Haemophilus influenzae. A European multi-centre study.
    Jones ME, Staples AM, Critchley I, Thornsberry C, Heinze P, Engler HD, Sahm DF.
    Diagn Microbiol Infect Dis; 2000 Jul; 37(3):203-11. PubMed ID: 10904194
    [Abstract] [Full Text] [Related]

  • 52. Antimicrobial resistance among respiratory pathogens collected in Thailand during 1999-2000.
    Critchley IA, Blosser-Middleton R, Jones ME, Yamakita J, Aswapokee N, Chayakul P, Tharavichitukul P, Vibhagool A, Thornsberry C, Karlowsky JA, Sahm DF.
    J Chemother; 2002 Apr; 14(2):147-54. PubMed ID: 12017369
    [Abstract] [Full Text] [Related]

  • 53. In vitro antibacterial activity of gemifloxacin and comparator compounds against common respiratory pathogens.
    Rittenhouse S, McCloskey L, Broskey J, Niconovich N, Jakielaszek C, Poupard J, Coleman K.
    J Antimicrob Chemother; 2000 Apr; 45 Suppl 1():23-7. PubMed ID: 10824028
    [Abstract] [Full Text] [Related]

  • 54. In vitro activity of telithromycin compared with macrolides and fluoroquinolones against Streptococcus pneumoniae, Haemophilus influenzae and Moraxella catarrhalis.
    Küçükbasmaci O, Gönüllü N, Aktaş Z, Gürol D, Berkiten R.
    Int J Antimicrob Agents; 2003 Nov; 22(5):497-501. PubMed ID: 14602368
    [Abstract] [Full Text] [Related]

  • 55. [Recent trends in incidence of respiratory tract pathogens and antimicrobial susceptibilities of Haemophilus influenzae, Streptococcus pneumoniae and Moraxella catarrhalis isolated in 1994 and 1995].
    Nishioka K, Ogihara H, Ohno I, Shirato K.
    Jpn J Antibiot; 1997 Sep; 50(9):768-75. PubMed ID: 9394237
    [Abstract] [Full Text] [Related]

  • 56. Antimicrobial activity of advanced-spectrum fluoroquinolones tested against more than 2000 contemporary bacterial isolates of species causing community-acquired respiratory tract infections in the United States (1999).
    Deshpande LM, Jones RN.
    Diagn Microbiol Infect Dis; 2000 Jun; 37(2):139-42. PubMed ID: 10863108
    [Abstract] [Full Text] [Related]

  • 57.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 58. [In vitro activity of 3 fluoroquinolones on Branhamella catarrhalis].
    Suermondt G, Denamur E, Laurans G, Orfila J.
    Pathol Biol (Paris); 1988 Jun; 36(5 Pt 2):647-50. PubMed ID: 3141885
    [Abstract] [Full Text] [Related]

  • 59. Comparative in vitro evaluation of dirithromycin tested against recent clinical isolates of Haemophilus influenzae, Moraxella catarrhalis, and Streptococcus pneumoniae, including effects of medium supplements and test conditions on MIC results.
    Biedenbach DJ, Jones RN, Lewis MT, Croco MA, Barrett MS.
    Diagn Microbiol Infect Dis; 1999 Apr; 33(4):275-82. PubMed ID: 10212755
    [Abstract] [Full Text] [Related]

  • 60. In vitro susceptibility of Streptococcus pneumoniae, Haemophilus influenzae and Moraxella catarrhalis: a European multicenter study during 2000-2001.
    Jones ME, Blosser-Middleton RS, Critchley IA, Karlowsky JA, Thornsberry C, Sahm DF.
    Clin Microbiol Infect; 2003 Jul; 9(7):590-9. PubMed ID: 12925097
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 19.